Editors' ChoiceCancer TAMing efferocytosis to fight tumors Christopher B. RodellSchool of Biomedical Engineering, Health, and Science Systems, Philadelphia, PA 19104, USA. Email: cbr58{at}drexel.edu See allHide authors and affiliations Science Translational Medicine 04 Mar 2020:Vol. 12, Issue 533, eabb0795DOI: 10.1126/scitranslmed.abb0795 Christopher B. Rodell School of Biomedical Engineering, Health, and Science Systems, Philadelphia, PA 19104, USA. Email: Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: cbr58@drexel.edu Article Info & Metrics eLetters Article Information vol. 12 no. 533 DOI: https://doi.org/10.1126/scitranslmed.abb0795 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: . Copyright & Usage: Copyright © 2020, American Association for the Advancement of Science Author Information Christopher B. RodellSchool of Biomedical Engineering, Health, and Science Systems, Philadelphia, PA 19104, USA. Email: cbr58{at}drexel.edu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: March 2020 to January 2021 AbstractFullPdf Mar 202021625099 Apr 2020194780 May 2020111991 Jun 202061685 Jul 202062653 Aug 202081174 Sep 20206750 Oct 2020159410 Nov 20208945 Dec 20205921 Jan 20213360 View Full Text
TAMing efferocytosis to fight tumors By Christopher B. Rodell Science Translational Medicine04 Mar 2020 Preventing clearance of dying tumor cells elicits an inflammatory response by macrophages, supporting development of antitumor immunity in mice.
TAMing efferocytosis to fight tumors By Christopher B. Rodell Science Translational Medicine04 Mar 2020 Preventing clearance of dying tumor cells elicits an inflammatory response by macrophages, supporting development of antitumor immunity in mice.